In conclusion, these data provide evidence that stroke‐induced impairments on B cells and antibodies are important determinants of post‐stroke infection susceptibility and targeting these pathways with IgM‐IVIg offers potential as a safe and effective method to reduce bacterial load and pathology in the lung after stroke. Here, CD40LG is linked to stroke disorder.